Basis: Trailing twelve months (TTM), to the latest fiscal quarter end. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the return on invested capital (ROIC) high or low?
The return on invested capital (ROIC) of -109.29% is 70% below its 5-year average of -64.34%, near the low end of its 5-year range (-109.29%–-25.67%).
As of the fiscal period ended Tuesday, June 30, 2026. 14.36% below its 12-month average of -95.57%.
Trailing-twelve-month return on invested capital at each fiscal quarter end; no daily interpolation. Q2 FY2026 (2026-06-30): -109.29%.
RETURN ON INVESTED CAPITAL (ROIC)
-109.29%
RETURN ON INVESTED CAPITAL (ROIC) AVG TTM
-95.57%
RETURN ON INVESTED CAPITAL (ROIC) AVG 3Y
-75.93%
RETURN ON INVESTED CAPITAL (ROIC) AVG 5Y
-64.34%
RETURN ON INVESTED CAPITAL (ROIC) AVG 10Y
-63.12%
RETURN ON INVESTED CAPITAL (ROIC) AVG 15Y
N/A
RETURN ON INVESTED CAPITAL (ROIC) AVG 20Y
N/A
CURRENT VS TTM AVG
-14.36%
CURRENT VS 3Y AVG
-43.93%
CURRENT VS 5Y AVG
-69.86%
CURRENT VS 10Y AVG
-73.14%
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
-33.73%
median of 743 covered companies
CURRENT VS SECTOR MEDIAN
-224.02%
vs the sector median at left
aTyr Pharma, Inc.
Market Cap
$28.49M
Return on Invested Capital (ROIC)
-109.29%
TTM Avg
-95.57%
3Y Avg
-75.93%
5Y Avg
-64.34%
Market Cap
$28.10M
Return on Invested Capital (ROIC)
-153.04%
TTM Avg
-84.65%
3Y Avg
-78.92%
5Y Avg
-71.84%
Market Cap
$27.89M
Return on Invested Capital (ROIC)
-103.04%
TTM Avg
-97.88%
3Y Avg
-84.76%
5Y Avg
-65.40%
Market Cap
$29.41M
Return on Invested Capital (ROIC)
-126.84%
TTM Avg
-48.51%
3Y Avg
-88.12%
5Y Avg
-74.86%
Market Cap
$29.60M
Return on Invested Capital (ROIC)
-99.36%
TTM Avg
-324.14%
3Y Avg
-260.84%
5Y Avg
-230.57%
Market Cap
$29.70M
Return on Invested Capital (ROIC)
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$29.88M
Return on Invested Capital (ROIC)
-42.23%
TTM Avg
-23.50%
3Y Avg
-191.16%
5Y Avg
-191.16%
Market Cap
$29.96M
Return on Invested Capital (ROIC)
N/A
TTM Avg
-54.98%
3Y Avg
-73.47%
5Y Avg
-75.57%
Market Cap
$29.99M
Return on Invested Capital (ROIC)
-15.35%
TTM Avg
-18.43%
3Y Avg
-24.75%
5Y Avg
-44.47%
| NAME | MARKET CAP | RETURN ON INVESTED CAPITAL (ROIC) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| aTyr Pharma, Inc. (ATYR) | $28.49M | -109.29% | -95.57% | -75.93% | -64.34% |
| InspireMD, Inc. (NSPR)vs › | $28.10M | -153.04% | -84.65% | -78.92% | -71.84% |
| Seres Therapeutics, Inc. (MCRB)vs › | $27.89M | -103.04% | -97.88% | -84.76% | -65.40% |
| Context Therapeutics Inc. (CNTX)vs › | $29.41M | -126.84% | -48.51% | -88.12% | -74.86% |
| Quantum Cyber N.V. (QUCY)vs › | $29.60M | -99.36% | -324.14% | -260.84% | -230.57% |
| OneMedNet Corporation (ONMD)vs › | $29.70M | N/A | N/A | N/A | N/A |
| GridAI Technologies Corp. (GRDX)vs › | $29.88M | -42.23% | -23.50% | -191.16% | -191.16% |
| BeyondSpring Inc. (BYSI)vs › | $29.96M | N/A | -54.98% | -73.47% | -75.57% |
| MDxHealth S.A. (MDXH)vs › | $29.99M | -15.35% | -18.43% | -24.75% | -44.47% |
| CervoMed Inc. (CRVO)vs › | $30.23M | -135.73% | -98.73% | -101.28% | -89.83% |
ROIC
-109.3%
ROE
-124.6%
ROIC = NOPAT / Invested Capital, where NOPAT = Operating Income × (1 − effective tax rate) and Invested Capital = Total Assets − (Current Liabilities − Short-Term Debt)
Return on invested capital measures the after-tax operating return a company earns on the capital invested in the business. TGMCharts computes it from reported statements: trailing-twelve-month operating income after tax, over invested capital at the latest balance sheet — total assets less the non-interest-bearing current liabilities (payables, accruals, deferred revenue) that fund them; short-term debt stays in the capital base. The tax rate is the period's own effective rate (income tax ÷ pretax income), capped at 45%; when pretax income is zero or negative, or the tax line is a net benefit, no tax is deducted — the operating figure is shown untaxed rather than adjusted by an assumed rate. Not shown for banks, insurers or funds.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | RETURN ON INVESTED CAPITAL (ROIC) |
|---|---|
| 2026-06-30 | -109.29% |
| 2026-03-31 | -105.54% |
| 2025-12-31 | -96.45% |
| 2025-09-30 | -85.12% |
| 2025-06-30 | -81.45% |
| 2025-03-31 | -77.46% |
| 2024-12-31 | -82.96% |
| 2024-09-30 | -87.81% |
| 2024-06-30 | -66.44% |
| 2024-03-31 | -60.42% |
| 2023-12-31 | -52.69% |
| 2023-09-30 | -41.81% |
| 2023-06-30 | -39.70% |
| 2023-03-31 | -38.00% |
| 2022-12-31 | -56.64% |
| 2022-09-30 | -55.51% |
| 2022-06-30 | -47.64% |
| 2022-03-31 | -39.78% |
| 2021-12-31 | -31.06% |
| 2021-09-30 | -25.67% |
| 2021-06-30 | -69.76% |
| 2021-03-31 | -49.28% |
| 2020-12-31 | -48.42% |
| 2020-09-30 | -46.18% |
| 2020-06-30 | -37.25% |
| 2020-03-31 | -29.96% |
| 2019-12-31 | -71.80% |
| 2019-09-30 | -57.79% |
| 2019-06-30 | -53.36% |
| 2019-03-31 | -61.20% |
| 2018-12-31 | -66.06% |
| 2018-09-30 | -67.01% |
| 2018-06-30 | -64.99% |
| 2018-03-31 | -59.29% |
| 2017-12-31 | -56.14% |
| 2017-09-30 | -55.69% |
| 2017-06-30 | -94.33% |
| 2017-03-31 | -91.30% |
| 2016-12-31 | -80.10% |
| 2016-09-30 | -80.77% |
| 2016-06-30 | -65.90% |
| 2016-03-31 | -52.02% |
| 2015-12-31 | -39.39% |
| 2015-09-30 | -27.35% |
| 2015-06-30 | -21.83% |
| 2015-03-31 | -49.57% |
| 2014-12-31 | -150.36% |
| 2014-09-30 | -106.26% |
